Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status final results of a phase 2 study (Burkimab)
dc.contributor.author | Alonso Vence, Natalia | |
dc.date.accessioned | 2017-06-07T07:13:25Z | |
dc.date.available | 2017-06-07T07:13:25Z | |
dc.date.issued | 2013 | |
dc.identifier.issn | 0008-543X | |
dc.identifier.uri | http://hdl.handle.net/20.500.11940/4015 | |
dc.language.iso | eng | |
dc.title | Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status final results of a phase 2 study (Burkimab) | |
dc.type | Artigo | es |
dc.authorsophos | Ribera, JM | |
dc.authorsophos | Garcia, O | |
dc.authorsophos | Grande, C | |
dc.authorsophos | Esteve, J | |
dc.authorsophos | Oriol, A | |
dc.authorsophos | Bergua, J | |
dc.authorsophos | Gonzalez-Campos, J | |
dc.authorsophos | Vall-Ilovera, F | |
dc.authorsophos | Tormo, M | |
dc.authorsophos | Hernandez-Rivas, JM | |
dc.authorsophos | Garcia, D | |
dc.authorsophos | Brunet, S | |
dc.authorsophos | Alonso, N | |
dc.authorsophos | Barba, P | |
dc.authorsophos | Miralles, P | |
dc.authorsophos | Llorente, A | |
dc.authorsophos | Montesinos, P | |
dc.authorsophos | Moreno, MJ | |
dc.authorsophos | Hernandez-Rivas, JA | |
dc.authorsophos | Bernal, T | |
dc.identifier.doi | 10.1002/cncr.27918 | |
dc.identifier.isi | 318115000009 | |
dc.identifier.pmid | 23361927 | |
dc.identifier.sophos | 13943 | |
dc.issue.number | 9 | |
dc.journal.title | CANCER | |
dc.organization | Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Hematoloxía clínica | |
dc.page.initial | 1660 | |
dc.page.final | 1668 | |
dc.rights.accessRights | openAccess | |
dc.typesophos | Artículo Original | |
dc.volume.number | 119 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |